September 2023 PMID 37467881

Preclinical investigations on broccoli-derived sulforaphane for the treatment of ophthalmic disease.

Faith A A Kwa, Bang V Bui, Bruce R Thompson, Lauren N Ayton

Mentions

12
Peak: 1 in Aug 2023
across 4 sources since Aug 2023

Extended reach

121,327
potential audience

Total likes

2,757

Video views

118,160

Mentions per month

Aug 2023 – Mar 2025

Where it's discussed

  • News5 articles
  • Facebook4 posts
  • YouTube2 videos
  • X / Twitter1 posts

AI synopsis

What people are saying

Several discussions highlight the potential of sulforaphane to slow or prevent vision loss, with phrases like 'promising results' and 'early-stage research' indicating cautious optimism. The tone balances scientific interest with acknowledgment that clinical applications are still forthcoming, reflecting a moderate expectation of impact and engagement.

AgreementModerate agreement

Most discussions recognize the potential of sulforaphane as a promising area for eye disease treatment, indicating a general consensus of support.

InterestModerate interest

Participants show moderate curiosity, often commenting on the relevance of the research to future therapies without overly enthusiastic tone.

EngagementModerate engagement

Posts include some detailed commentary on the scientific mechanisms and potential clinical implications, suggesting a reasonable level of discussion depth.

ImpactNeutral impact

While some acknowledge the hope for new treatments, many discussions remain speculative; thus, the perceived immediate impact is moderate.

Abstract in brief

  • The text discusses how vision loss from conditions like AMD, diabetic retinopathy, glaucoma, and retinitis pigmentosa poses significant health and social challenges, especially as the global population ages.
  • Sulforaphane (SFN), a compound derived from broccoli, has shown promising health benefits and multiple mechanisms of action in preclinical studies related to eye diseases.
  • The review emphasizes the need for further clinical testing of SFN to develop new therapies that can target early stages of eye diseases and potentially prevent or slow vision loss.]

Top posts

Most liked on X and Bluesky
DrRPalmquist
@DrPalmquist · X

Preclinical investigations on broccoli-derived sulforaphane for the treatment of ophthalmic disease https://t.co/VbnKnsgFXe

Sep 30, 2023 · 1 like · 3,168 followers View post →

All mentions

DrRPalmquist
@DrPalmquist · X

Preclinical investigations on broccoli-derived sulforaphane for the treatment of ophthalmic disease https://t.co/VbnKnsgFXe

Sep 30, 2023 · 1 like · 3,168 followers View post →